Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 2/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | CA1 | P00915 | 3/20 | 0.42 |
| ▸ | CA2 | P00918 | 3/20 | 0.42 |
| ▸ | CA12 | O43570 | 2/20 | 0.42 |
| ▸ | CA9 | Q16790 | 2/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8380124 | 1.00 | TP53 (0.44) | TP53ALOX15ALDH1A1KDM4ECA1 | |
| SCHEMBL9801087 | 1.00 | TP53 (0.44) | TP53ALOX15ALDH1A1KDM4ECA1 | |
| SCHEMBL9801607 | 1.00 | TP53 (0.44) | TP53ALOX15ALDH1A1KDM4ECA1 | |
| SCHEMBL9801759 | 1.00 | TP53 (0.44) | TP53ALOX15ALDH1A1KDM4ECA1 | |
| SCHEMBL9801081 | 1.00 | TP53 (0.44) | TP53ALOX15ALDH1A1KDM4ECA1 | |
| SCHEMBL8453720 | 1.00 | TP53 (0.44) | TP53ALOX15ALDH1A1KDM4ECA1 | |
| SCHEMBL9801155 | 1.00 | TP53 (0.44) | TP53ALOX15ALDH1A1KDM4ECA1 | |
| SCHEMBL9548174 | 1.00 | TP53 (0.44) | TP53ALOX15ALDH1A1KDM4ECA1 | |
| SCHEMBL9801631 | 1.00 | TP53 (0.44) | TP53ALOX15ALDH1A1KDM4ECA1 | |
| SCHEMBL9801036 | 1.00 | TP53 (0.44) | TP53ALOX15ALDH1A1KDM4ECA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115472900-A | Polyurethane type composite solid electrolyte and preparation method and application thereof | 浙江凌骁能源科技有限公司 | 2022-12-13 | — | — | CN | claimed |
| US-20240226132-A1 | RNA COMPOSITIONS COMPRISING A BUFFER SUBSTANCE AND METHODS FOR PREPARING, STORING AND USING THE SAME | BIONTECH DELIVERY TECHNOLOGIES GMBH (DE) | 2024-07-11 | — | — | US | disclosed |
| US-11839657-B2 | Ionizable lipids and compositions for nucleic acid delivery | WESTGENE BIOPHARMA CO., LTD (CN) | 2023-12-12 | — | — | US | disclosed |
| US-11839700-B2 | Bio-electrode composition, bio-electrode, and method for manufacturing a bio-electrode | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-12-12 | — | — | US | disclosed |
| WO-2023125889-A1 | QUADRIVALENT MRNA VACCINES FOR INFLUENZA VIRUSES | Suzhou Abogen Biosciences Co., Ltd. (CN) | 2023-07-06 | — | — | WO | disclosed |
| WO-2023098842-A1 | NUCLEIC ACID VACCINES FOR CORONAVIRUS BASED ON SEQUENCES DERIVED FROM SARS-CoV-2 OMICRON STRAIN | Suzhou Abogen Biosciences Co., Ltd. (CN) | 2023-06-08 | — | — | WO | disclosed |
| WO-2023056911-A1 | MULTIVALENT NUCLEIC ACID VACCINES FOR CORONAVIRUS BASED ON SEQUENCES DERIVED FROM SARS-CoV-2 BETA AND DELTA STRAINS | Suzhou Abogen Biosciences Co., Ltd. (CN) | 2023-04-13 | — | — | WO | disclosed |
| CN-115472900-A | Polyurethane type composite solid electrolyte and preparation method and application thereof | 浙江凌骁能源科技有限公司 | 2022-12-13 | — | — | CN | disclosed |
| US-20220112152-A1 | TRIPHENYLPHOSPHONIUM-TETHERED SALICYLAMINE DERIVATIVES | MTI BIOTECH, INC. | 2022-04-14 | — | — | US | disclosed |
| US-20180215876-A1 | STRETCHABLE FILM AND METHOD FOR FORMING THE STRETCHABLE FILM | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2018-08-02 | — | — | US | disclosed |
| US-20120037860-A1 | DYE-CONTAINING NEGATIVE CURABLE COMPOSITION, COLOR FILTER AND METHOD FOR PRODUCING THE SAME | FUJIFILM CORPORATION (JP) | 2012-02-16 | — | — | US | disclosed |
| US-20110293703-A1 | AMINOALCOHOL LIPIDOIDS AND USES THEREOF | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2011-12-01 | — | — | US | disclosed |
| US-20110052673-A1 | THERAPEUTIC COMPOSITIONS | SHIRE HUMAN GENETIC THERAPIES, INC. | 2011-03-03 | — | — | US | disclosed |
| US-20110009641-A1 | Amine-containing lipids and uses thereof | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2011-01-13 | — | — | US | disclosed |
| US-20100331234-A1 | AMINOALCOHOL LIPIDOIDS AND USES THEREOF | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2010-12-30 | — | — | US | disclosed |
| US-4992150-A | Telomer with alpha-olefin;oil and fuel additive | NIPPON OIL CO, LTD. (JP) | 1991-02-12 | — | — | US | disclosed |
| US-4900795-A | PHOTOPOLMERIZABLE POLYMER COMPRISING ETHYLENE, (METH)ACRYLIC ACID AND VINYL OR ACRYLATE MONOMER NEUTRALIZED BY A CYCLIC AMINE OR HYDROXY-CONTAINING AMINE; PHOTORESISTS; PRINTING PLATES; OZONE RESISTANCE; ELONGATION; TENSILE STRENGTH | BASF AKTIENGESELLSCHAFT (DE) | 1990-02-13 | — | — | US | disclosed |
| EP-0293750-A2 | Polymer ammonium salts | BASF Aktiengesellschaft (DE) | 1988-12-07 | — | — | EP | disclosed |
| EP-0055444-B1 | TRISUBSTITUTED PYRIMIDO(5,4-D)PYRIMIDINES, THEIR PREPARATION AND MEDICAMENTS CONTAINING THEM | Dr. Karl Thomae GmbH (DE) | 1985-03-20 | — | — | EP | disclosed |
| US-4478833-A | ANTICOAGULANTS | DR. KARL THOMAE GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1984-10-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220112152-A1 | TRIPHENYLPHOSPHONIUM-TETHERED SALICYLAMINE DERIVATIVES | SHMT2, HSPA9, GOT2 | TP53 1704/4885ALOX15 1395/4885ALDH1A1 2656/4885 |
| US-20110052673-A1 | THERAPEUTIC COMPOSITIONS | PHOSPHO1, SGMS1, APOB | TP53 1406/4885ALOX15 266/4885ALDH1A1 2111/4885 |
| US-20110293703-A1 | AMINOALCOHOL LIPIDOIDS AND USES THEREOF | PHOSPHO1, PNMT, AASDHPPT | TP53 3789/4885ALOX15 48/4885ALDH1A1 568/4885 |
| US-20110009641-A1 | Amine-containing lipids and uses thereof | PHOSPHO1, CHMP4B, SGMS1 | TP53 3188/4885ALOX15 499/4885ALDH1A1 1430/4885 |
| US-11839657-B2 | Ionizable lipids and compositions for nucleic acid delivery | POLRMT, POLN, NPC1L1 | TP53 1984/4885ALOX15 1868/4885ALDH1A1 2489/4885 |
| US-20240226132-A1 | RNA COMPOSITIONS COMPRISING A BUFFER SUBSTANCE AND METHODS FOR PREPARING, STORING AND USING THE SAME | SNRPB2, NSUN2, RNMT | TP53 237/4885ALOX15 3713/4885ALDH1A1 3185/4885 |
| US-20100331234-A1 | AMINOALCOHOL LIPIDOIDS AND USES THEREOF | PHOSPHO1, PNMT, AASDHPPT | TP53 3789/4885ALOX15 48/4885ALDH1A1 568/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.